PharmaLogic is a specialty nuclear pharmacy business, operating from rural pharmacies and distributing compounded isotopes to hospitals and clinics in secondary markets across the East Coast and northern Midwest of the United States. The company is one of the largest independent specialty nuclear pharmacies in the industry. The compounded isotopes created by PharmaLogic are used by doctors to highlight organ activity in patients undergoing SPECT imaging tests.
Details.
Status:
Current
Year Invested:
2015
Website:
www.pharmalogic.info
Category:
Healthcare
Fund:
Fund III